Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 1
2019 3
2020 3
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
Longo V, Brunetti O, Gnoni A, Licchetta A, Delcuratolo S, Memeo R, Solimando AG, Argentiero A. Longo V, et al. Among authors: delcuratolo s. Medicina (Kaunas). 2019 Oct 17;55(10):698. doi: 10.3390/medicina55100698. Medicina (Kaunas). 2019. PMID: 31627433 Free PMC article. Review.
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.
Brunetti O, Gnoni A, Licchetta A, Longo V, Calabrese A, Argentiero A, Delcuratolo S, Solimando AG, Casadei-Gardini A, Silvestris N. Brunetti O, et al. Among authors: delcuratolo s. Medicina (Kaunas). 2019 Oct 21;55(10):707. doi: 10.3390/medicina55100707. Medicina (Kaunas). 2019. PMID: 31640191 Free PMC article. Review.
Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.
Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S, Silvestris N. Gnoni A, et al. Among authors: delcuratolo s. Int J Mol Sci. 2013 Sep 30;14(10):19731-62. doi: 10.3390/ijms141019731. Int J Mol Sci. 2013. PMID: 24084722 Free PMC article. Review.
Predictive factors to targeted treatment in gastrointestinal carcinomas.
Silvestris N, Marech I, Brunetti AE, Azzariti A, Numico G, Cicero G, Delcuratolo S, De Luca R, Burz C, Lorusso V. Silvestris N, et al. Among authors: delcuratolo s. Cancer Biomark. 2014;14(2-3):151-62. doi: 10.3233/CBM-130327. Cancer Biomark. 2014. PMID: 24878816 Review.
MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O, Russo A, Scarpa A, Santini D, Reni M, Bittoni A, Azzariti A, Aprile G, Delcuratolo S, Signorile M, Gnoni A, Palermo L, Lorusso V, Cascinu S, Silvestris N. Brunetti O, et al. Among authors: delcuratolo s. Oncotarget. 2015 Sep 15;6(27):23323-41. doi: 10.18632/oncotarget.4492. Oncotarget. 2015. PMID: 26259238 Free PMC article. Review.
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Corradini P, Agrati C, Apolone G, Mantovani A, Giannarelli D, Marasco V, Bordoni V, Sacchi A, Matusali G, Salvarani C, Zinzani PL, Mantegazza R, Tagliavini F, Lupo-Stanghellini MT, Ciceri F, Damian S, Uccelli A, Fenoglio D, Silvestris N, Baldanti F, Piaggio G, Ciliberto G, Morrone A, Locatelli F, Sinno V, Rescigno M, Costantini M; VAX4FRAIL Study Group. Corradini P, et al. Clin Infect Dis. 2023 Feb 8;76(3):e426-e438. doi: 10.1093/cid/ciac404. Clin Infect Dis. 2023. PMID: 35607769 Free PMC article.
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines.
Silvestris N, Del Re M, Azzariti A, Maiello E, Lombardi L, Cinieri S, Guarini A, Brunetti AE, Delcuratolo S, De Vita F, Pisconti S, Danesi R, Colucci G. Silvestris N, et al. Among authors: delcuratolo s. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S111-7. doi: 10.1517/14728222.2011.652089. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443211 Review.
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study.
Silvestris N, Argentiero A, Brunetti O, Sonnessa M, Colonna F, Delcuratolo S, Luchini C, Scarpa A, Lonardi S, Nappo F, Fassan M, Solimando AG, Fucci L, Saponaro C. Silvestris N, et al. Among authors: delcuratolo s. Expert Opin Ther Targets. 2021 Nov;25(11):1007-1016. doi: 10.1080/14728222.2021.2011859. Epub 2021 Dec 20. Expert Opin Ther Targets. 2021. PMID: 34846251
15 results